Concepedia

Alia Fleury

AF

5

Publications

256

Citations

5

H-Index

2019

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Moffitt Cancer Center

Baylor College of Medicine

University of California, Davis

University of Kansas Medical Center

Alia Fleury is an author at The University of Texas MD Anderson Cancer Center specializing in cancer cell biology, immunology, and tumor biology.

ORCID

Top concepts

Publications per year

2019–2021

5

Publications

5

Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer

Johannes F. Fahrmann, Jody V. Vykoukal, Alia Fleury et al. · JNCI Journal of the National Cancer Institute · 2019 · 103 citations · Full text

Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer

Jody V. Vykoukal, Johannes F. Fahrmann, Justin R. Gregg et al. · Nature Communications · 2020 · 79 citations · Full text

ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression

Julian Burks, Alia Fleury, Sarah Livingston et al. · Cancer Immunology Immunotherapy · 2019 · 40 citations · Full text

, , +8

CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop

Yihui Chen, Michela Capello, Mayrim V. Rios Perez et al. · Molecular Metabolism · 2021 · 18 citations · Full text

CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes

Michela Capello, Johannes F. Fahrmann, Mayrim V. Rios Perez et al. · JCO Precision Oncology · 2020 · 16 citations · Full text

Rows per page

1–5 of 5